Renaissance Technologies’s Anebulo Pharmaceuticals ANEB Stock Holding History

Renaissance Technologies’s Portfolio ANEB Stock Details ANEB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,098	Closed	-$25.3K	–	3234
2025 Q4	$25.3K	Sell	25,098 -3,402	-12%	-$7.76K	﹤0.01%	3132
2025 Q3	$71.3K	Buy	+28,500	New	+$67.1K	﹤0.01%	3299

Renaissance Technologies's ANEB Position: Q1 2026 in Review

Renaissance Technologies sold out of Anebulo Pharmaceuticals (ANEB) in Q1 2026, closing a stake of 25,098 shares — an estimated $25.3K sold.

Renaissance Technologies first reported a position in ANEB in Q3 2025 and held it in 2 quarters. The position peaked at $71.3K in Q3 2025. 0 funds tracked by Wall St. Rank hold ANEB as of Q1 2026.

Renaissance Technologies reported no remaining Anebulo Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Renaissance Technologies sold 25,098 Anebulo Pharmaceuticals shares in Q1 2026, an estimated $25.3K.
Renaissance Technologies first reported a position in Anebulo Pharmaceuticals in Q3 2025 and held it in 2 quarters.
Renaissance Technologies's Anebulo Pharmaceuticals position peaked at $71.3K in Q3 2025.
0 funds tracked by Wall St. Rank held Anebulo Pharmaceuticals as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.